Transaction in Own Shares

Summary by AI BETAClose X

Fevertree Drinks plc has announced the purchase of 163,500 ordinary shares between October 12th and October 16th, 2026, through its broker Investec Bank plc. The volume-weighted average price for these purchases ranged from 868.50p to 915.54p, with the lowest price per share at 864.00p and the highest at 922.50p. The company intends to cancel these repurchased shares.

Disclaimer*

Fevertree Drinks PLC
20 October 2026
 

20th October 2026  

Fevertree Drinks plc

(“Fever-Tree” or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc (“Fever-Tree” or the “Company”) announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the “Ordinary Shares”) through the Company’s broker, Investec Bank plc (“Investec”) in the period from 12th October to 16th October 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

12 October 2026

XLON

876.8390

17,871

864.0000

883.0000

13 October 2026

XLON

882.6842

33,971

864.5000

894.0000

13 October 2026

AIMX

868.5000

2,793

868.5000

868.5000

14 October 2026

XLON

879.9026

37,307

872.0000

890.0000

15 October 2026

XLON

890.3414

36,122

879.0000

907.0000

16 October 2026

XLON

915.5390

31,374

903.0000

922.5000

16 October 2026

AIMX

911.5000

4,146

911.5000

911.5000

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases – Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/4844Z_1-2026-10-19.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 7435 828 138

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings